CLINICAL_TRIALS
trial_result
· 2017-05-11
Clinical Trial Update: Pharmacogenetic Response to Naltrexone For Alcohol Dependence [Phase 4]
Summary
Phase 4 study examining pharmacogenetic factors influencing how people with alcohol dependence respond to naltrexone; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David Oslin | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED | Results posted: 2017-05-11